MAS1L and diabetic kidney disease: In addition, the increased expression of ACE2 and Ang-(1-7) can down-regulate the related inflammatory pathways through ACE2/Ang-(1-7)/MasR axis, play a role in anti-inflammatory and anti-fibrosis, and delay the process of diabetic nephropathy (42, 43).